Get my own profile
Public access
View all163 articles
20 articles
available
not available
Based on funding mandates
Co-authors
- Oliver BurtonUniversity of CambridgeVerified email at cam.ac.uk
- Chris GoodnowGarvan Institute of Medical Research, University of New South Wales SydneyVerified email at garvan.org.au
- Michelle LintermanGroup Leader, Babraham InstituteVerified email at babraham.ac.uk
- Isabelle MeytsVerified email at uzleuven.be
- Diether LambrechtsLaboratory for Translational Genetics, Department of Oncology, VIB and KULeuven, Leuven, BelgiumVerified email at vib-kuleuven.be
- Sylvie LesageProfessor of Immunology, Université de MontréalVerified email at umontreal.ca
- Vasiliki LagouAutoimmune Genetics Laboratory, VIB, Leuven 3000, BelgiumVerified email at well.ox.ac.uk
- Bart De Stroopergewoon hoogleraar KU Leuven en onderzoeksdirecteur VIBVerified email at cme.vib-kuleuven.be
- Kim A. StaatsDirector of Rare Disease Drug Development, INmune BioVerified email at inmunebio.com
- Carola G VinuesaThe Francis Crick InstituteVerified email at anu.edu.au
- Dina Danso-AbeamSenior Scientist, Legend BiotechVerified email at legendbiotech.com
- Owen SiggsGarvan Institute of Medical ResearchVerified email at garvan.org.au
- Jeroen RaesProfessor, Faculty of Medicine, Rega Institute, KU Leuven; Group Leader Microbiome, VIB, BelgiumVerified email at med.kuleuven.be
- Li-Fan LuUniversity of California, San DiegoVerified email at ucsd.edu
- alexander rudenskymskccVerified email at mskcc.org
- Ludo Van Den BoschKU Leuven & VIBVerified email at kuleuven.vib.be
- Lydia MakaroffFight Bladder CancerVerified email at fightbladdercancer.co.uk
- Aikaterini Smaragdi PapadopoulouUniversity College LondonVerified email at ucl.ac.uk
- Bernard ThienpontLaboratory of Functional Epigenetics - KULeuven, BelgiumVerified email at kuleuven.be
- Peter Carmeliethoogleraar, Universiteit van Leuven, VIBVerified email at kuleuven.vib.be